BP Lipid 135
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | SM-102 & Analogs |
| Catalog NO. | BPG-3733 |
| Product Name | BP Lipid 135 |
| CAS | 2089251-35-2 |
| Molecular Formula | C45H89NO5 |
| Molecular Weight | 724.2 |
- Scheme Design
- Custom Synthesis
- cGMP Manufacturing
- Quality Assurance
- Product Information
- Documents
- Reviews
Product Information
| Description | BP Lipid 135 is an amino ionizable lipid with propanolamine lipid head which can improve mRNA encapsulation. The ester bonds are located at C8 position relative to nitrogen amine. There is 9 carbons chain on the primary ester lipid tail. The lipid can be used for preparation mRNA vesicle in gene therapy. |
| Synonyms | BP Lipid 135; Heptadecan-9-yl 8-((3-hydroxypropyl)(8-(nonyloxy)-8-oxooctyl)amino)octanoate; 2089251-35-2; starbld0005410; SCHEMBL18641752; HY-W440779; BP-26392; CS-0436140 |
| IUPAC Name | nonyl 8-[(8-heptadecan-9-yloxy-8-oxooctyl)-(3-hydroxypropyl)amino]octanoate |
| SMILES | CCCCCCCCCOC(=O)CCCCCCCN(CCCCCCCC(=O)OC(CCCCCCCC)CCCCCCCC)CCCO |
| InChI | InChI=1S/C45H89NO5/c1-4-7-10-13-16-25-32-42-50-44(48)36-28-21-17-23-30-38-46(40-33-41-47)39-31-24-18-22-29-37-45(49)51-43(34-26-19-14-11-8-5-2)35-27-20-15-12-9-6-3/h43,47H,4-42H2,1-3H3 |
| InChIKey | DSNJXBBGALIZJN-UHFFFAOYSA-N |
| Purity | 0.9 |
| Storage | -20°C |
Reviews
If you have any suggestions or comments about BP Lipid 135 , please submit a review immediately.
Why BOC Sciences?
-
Large Stock
More than 2000+ products in inventory
-
Global Delivery
Warehouses in multiple cities to ensure fast delivery
-
mg to kg
Multi specification for academic research and industrial production
-
24/7 Technical Support
Strict process parameter control to ensure product quality
Our Feature
BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.
PEGylation of Peptides
and Proteins
Reduce the Immunogenicity of Peptide/Protein Drugs
Learn More
APPLICATIONS
PEG linkers For Drug
Improved Circulation Half-Life
Learn More
Have Customer
Reviewed On Us?
Chat With Us